Crystal structure of Aurora-2 protein and binding pockets thereof
    1.
    发明授权
    Crystal structure of Aurora-2 protein and binding pockets thereof 失效
    Aurora-2蛋白的晶体结构及其结合口袋

    公开(公告)号:US08124392B2

    公开(公告)日:2012-02-28

    申请号:US12890826

    申请日:2010-09-27

    IPC分类号: C12N9/12 G01N31/00

    CPC分类号: C12N9/1205 C07K2299/00

    摘要: The present invention provides crystalline molecules or molecular complexes which comprise binding pockets of Aurora-2 or its homologues. The invention also provides crystals comprising Aurora-2. The present invention also relates to a computer comprising a data storage medium encoded with the structural coordinates of Aurora-2 binding pockets and methods of using a computer to evaluate the ability of a compound to bind to the molecule or molecular complex. This invention also provides methods of using the structure coordinates to solve the structure of homologous proteins or protein complexes. In addition, this invention provides methods of using the structure coordinates to screen for and design compounds, including inhibitory compounds, that bind to Aurora-2 or homologues thereof.

    摘要翻译: 本发明提供包含Aurora-2或其同系物的结合口袋的结晶分子或分子复合物。 本发明还提供了包含Aurora-2的晶体。 本发明还涉及包含用Aurora-2结合口袋的结构座标编码的数据存储介质的计算机,以及使用计算机评价化合物结合分子或分子复合物的能力的方法。 本发明还提供了使用结构坐标来解决同源蛋白质或蛋白质复合物的结构的方法。 此外,本发明提供了使用结构坐标筛选和设计结合Aurora-2或其同系物的化合物(包括抑制性化合物)的方法。

    Crystal structure of aurora-2 protein and binding pockets thereof
    2.
    发明授权
    Crystal structure of aurora-2 protein and binding pockets thereof 失效
    极光-2蛋白的晶体结构及其结合口袋

    公开(公告)号:US07809541B2

    公开(公告)日:2010-10-05

    申请号:US12070054

    申请日:2008-02-13

    IPC分类号: G06G7/58 C12N9/12

    CPC分类号: C12N9/1205 C07K2299/00

    摘要: The present invention provides crystalline molecules or molecular complexes which comprise binding pockets of Aurora-2 or its homologues. The invention also provides crystals comprising Aurora-2. The present invention also relates to a computer comprising a data storage medium encoded with the structural coordinates of Aurora-2 binding pockets and methods of using a computer to evaluate the ability of a compound to bind to the molecule or molecular complex. This invention also provides methods of using the structure coordinates to solve the structure of homologous proteins or protein complexes. In addition, this invention provides methods of using the structure coordinates to screen for and design compounds, including inhibitory compounds, that bind to Aurora-2 or homologues thereof.

    摘要翻译: 本发明提供包含Aurora-2或其同系物的结合口袋的结晶分子或分子复合物。 本发明还提供了包含Aurora-2的晶体。 本发明还涉及包含用Aurora-2结合口袋的结构座标编码的数据存储介质的计算机,以及使用计算机评价化合物结合分子或分子复合物的能力的方法。 本发明还提供了使用结构坐标来解决同源蛋白质或蛋白质复合物的结构的方法。 此外,本发明提供了使用结构坐标筛选和设计结合Aurora-2或其同系物的化合物(包括抑制性化合物)的方法。

    Crystal structure of aurora-2 protein and binding pockets thereof
    3.
    发明申请
    Crystal structure of aurora-2 protein and binding pockets thereof 失效
    极光-2蛋白的晶体结构及其结合口袋

    公开(公告)号:US20090287422A1

    公开(公告)日:2009-11-19

    申请号:US12070054

    申请日:2008-02-13

    IPC分类号: G06F19/00 G06G7/60

    CPC分类号: C12N9/1205 C07K2299/00

    摘要: The present invention provides crystalline molecules or molecular complexes which comprise binding pockets of Aurora-2 or its homologues. The invention also provides crystals comprising Aurora-2. The present invention also relates to a computer comprising a data storage medium encoded with the structural coordinates of Aurora-2 binding pockets and methods of using a computer to evaluate the ability of a compound to bind to the molecule or molecular complex. This invention also provides methods of using the structure coordinates to solve the structure of homologous proteins or protein complexes. In addition, this invention provides methods of using the structure coordinates to screen for and design compounds, including inhibitory compounds, that bind to Aurora-2 or homologues thereof.

    摘要翻译: 本发明提供包含Aurora-2或其同系物的结合口袋的结晶分子或分子复合物。 本发明还提供了包含Aurora-2的晶体。 本发明还涉及包含用Aurora-2结合口袋的结构座标编码的数据存储介质的计算机,以及使用计算机评价化合物结合分子或分子复合物的能力的方法。 本发明还提供了使用结构坐标来解决同源蛋白质或蛋白质复合物的结构的方法。 此外,本发明提供了使用结构坐标筛选和设计结合Aurora-2或其同系物的化合物(包括抑制性化合物)的方法。

    Crystal structure of aurora-2 protein and binding pockets thereof
    4.
    发明授权
    Crystal structure of aurora-2 protein and binding pockets thereof 失效
    极光-2蛋白的晶体结构及其结合口袋

    公开(公告)号:US07361492B2

    公开(公告)日:2008-04-22

    申请号:US10979375

    申请日:2004-11-01

    IPC分类号: C12N9/12 G01N31/00

    CPC分类号: C12N9/1205 C07K2299/00

    摘要: The present invention provides crystalline molecules or molecular complexes which comprise binding pockets of Aurora-2 or its homologues. The invention also provides crystals comprising Aurora-2. The present invention also relates to a computer comprising a data storage medium encoded with the structural coordinates of Aurora-2 binding pockets and methods of using a computer to evaluate the ability of a compound to bind to the molecule or molecular complex. This invention also provides methods of using the structure coordinates to solve the structure of homologous proteins or protein complexes. In addition, this invention provides methods of using the structure coordinates to screen for and design compounds, including inhibitory compounds, that bind to Aurora-2 or homologues thereof.

    摘要翻译: 本发明提供包含Aurora-2或其同系物的结合口袋的结晶分子或分子复合物。 本发明还提供了包含Aurora-2的晶体。 本发明还涉及包含用Aurora-2结合口袋的结构座标编码的数据存储介质的计算机,以及使用计算机评价化合物结合分子或分子复合物的能力的方法。 本发明还提供了使用结构坐标来解决同源蛋白质或蛋白质复合物的结构的方法。 此外,本发明提供了使用结构坐标筛选和设计结合Aurora-2或其同系物的化合物(包括抑制性化合物)的方法。

    CRYSTAL STRUCTURE OF AURORA-2 PROTEIN AND BINDING POCKETS THEREOF
    5.
    发明申请
    CRYSTAL STRUCTURE OF AURORA-2 PROTEIN AND BINDING POCKETS THEREOF 失效
    AURORA-2蛋白质的结晶结构及其结合点

    公开(公告)号:US20110104782A1

    公开(公告)日:2011-05-05

    申请号:US12890826

    申请日:2010-09-27

    IPC分类号: C12N9/96 C12N9/12

    CPC分类号: C12N9/1205 C07K2299/00

    摘要: The present invention provides crystalline molecules or molecular complexes which comprise binding pockets of Aurora-2 or its homologues. The invention also provides crystals comprising Aurora-2. The present invention also relates to a computer comprising a data storage medium encoded with the structural coordinates of Aurora-2 binding pockets and methods of using a computer to evaluate the ability of a compound to bind to the molecule or molecular complex. This invention also provides methods of using the structure coordinates to solve the structure of homologous proteins or protein complexes. In addition, this invention provides methods of using the structure coordinates to screen for and design compounds, including inhibitory compounds, that bind to Aurora-2 or homologues thereof.

    摘要翻译: 本发明提供包含Aurora-2或其同系物的结合口袋的结晶分子或分子复合物。 本发明还提供了包含Aurora-2的晶体。 本发明还涉及包含用Aurora-2结合口袋的结构座标编码的数据存储介质的计算机,以及使用计算机评价化合物结合分子或分子复合物的能力的方法。 本发明还提供了使用结构坐标来解决同源蛋白质或蛋白质复合物的结构的方法。 此外,本发明提供了使用结构坐标筛选和设计结合Aurora-2或其同系物的化合物(包括抑制性化合物)的方法。

    Crystal structure of aurora-2 protein and binding pockets thereof
    6.
    发明申请
    Crystal structure of aurora-2 protein and binding pockets thereof 失效
    极光-2蛋白的晶体结构及其结合口袋

    公开(公告)号:US20050143402A1

    公开(公告)日:2005-06-30

    申请号:US10979375

    申请日:2004-11-01

    CPC分类号: C12N9/1205 C07K2299/00

    摘要: The present invention provides crystalline molecules or molecular complexes which comprise binding pockets of Aurora-2 or its homologues. The invention also provides crystals comprising Aurora-2. The present invention also relates to a computer comprising a data storage medium encoded with the structural coordinates of Aurora-2 binding pockets and methods of using a computer to evaluate the ability of a compound to bind to the molecule or molecular complex. This invention also provides methods of using the structure coordinates to solve the structure of homologous proteins or protein complexes. In addition, this invention provides methods of using the structure coordinates to screen for and design compounds, including inhibitory compounds, that bind to Aurora-2 or homologues thereof.

    摘要翻译: 本发明提供包含Aurora-2或其同系物的结合口袋的结晶分子或分子复合物。 本发明还提供了包含Aurora-2的晶体。 本发明还涉及包含用Aurora-2结合口袋的结构座标编码的数据存储介质的计算机,以及使用计算机评价化合物结合分子或分子复合物的能力的方法。 本发明还提供了使用结构坐标来解决同源蛋白质或蛋白质复合物的结构的方法。 此外,本发明提供了使用结构坐标筛选和设计结合Aurora-2或其同系物的化合物(包括抑制性化合物)的方法。

    Crystal structure of interleukin-2 tyrosine kinase (ITK) and binding pockets thereof
    7.
    发明申请
    Crystal structure of interleukin-2 tyrosine kinase (ITK) and binding pockets thereof 审中-公开
    白细胞介素-2酪氨酸激酶(ITK)的晶体结构及其结合口袋

    公开(公告)号:US20060030016A1

    公开(公告)日:2006-02-09

    申请号:US11003787

    申请日:2004-12-03

    摘要: The invention relates to molecules or molecular complexes which comprise binding pockets of ITK or its structural homologues. The invention relates to crystallizable compositions and crystals comprising ITK. The present invention also relates to a data storage medium encoded with the structural coordinates of molecules and molecular complexes which comprise the ITK or ITK-like ATP-binding pockets. The present invention also relates to a computer comprising such data storage material. The computer may generate a three-dimensional structure or graphical three-dimensional representation of such molecules or molecular complexes. This invention also relates to methods of using the structure coordinates to solve the structure of homologous proteins or protein complexes. In addition, this invention relates to methods of using the structure coordinates to screen for and design compounds, including inhibitory compounds, that bind to ITK or homologues thereof.

    摘要翻译: 本发明涉及包含ITK或其结构同系物的结合口袋的分子或分子复合物。 本发明涉及可结晶组合物和包含ITK的晶体。 本发明还涉及一种数据存储介质,其编码有包含ITK或ITK样ATP结合口袋的分子和分子复合物的结构坐标。 本发明还涉及包含这种数据存储材料的计算机。 计算机可以产生这种分子或分子复合物的三维结构或图形三维表示。 本发明还涉及使用结构坐标来解决同源蛋白质或蛋白质复合物的结构的方法。 此外,本发明涉及使用结构坐标来筛选和设计结合ITK或其同系物的化合物(包括抑制性化合物)的方法。

    Caspase inhibitors and uses thereof
    8.
    发明授权
    Caspase inhibitors and uses thereof 有权
    胱天蛋白酶抑制剂及其用途

    公开(公告)号:US07807659B2

    公开(公告)日:2010-10-05

    申请号:US11522375

    申请日:2006-09-14

    IPC分类号: A61K31/675 A01N57/00

    摘要: The present invention relates to novel classes of compounds of formula I which are caspase and TNF-alpha inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting caspase and TNF-alpha activity and consequently, can be advantageously used as agents against caspase-, interleukin-1-(“IL-1”), apoptosis-, interferon-γ inducing factor-(IGIF), interferon-γ-(“IFN-γ”), or TNF-alpha mediated diseases, including inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, and degenerative diseases. This invention also relates to processes for preparing the compounds of this invention. This invention also relates to methods for inhibiting caspase and TNF-alpha activity and decreasing IGIF production and IFN-γ production and methods for treating caspase-, interleukin-1, apoptosis-, and interferon-γ-, and TNF-alpha mediated diseases using the compounds and compositions of this invention.

    摘要翻译: 本发明涉及新型的式I化合物,其为半胱天冬酶和TNF-α抑制剂。 本发明还涉及包含这些化合物的药物组合物。 本发明的化合物和药物组合物特别适用于抑制半胱天冬酶和TNF-α活性,因此可有利地用作抗半胱天冬酶,白细胞介素-1(“IL-1”),细胞凋亡 - 干扰素 - γ诱导因子(IGIF),干扰素-γ-(“IFN-γ”)或TNF-α介导的疾病,包括炎性疾病,自身免疫性疾病,破坏性骨病,增殖性疾病,感染性疾病和退行性疾病。 本发明还涉及制备本发明化合物的方法。 本发明还涉及用于抑制半胱天冬酶和TNF-α活性并减少IGIF产生和IFN-γ产生的方法以及用于治疗半胱天冬酶,白细胞介素-1,细胞凋亡和干扰素-γ以及TNF-α介导的疾病的方法 本发明的化合物和组合物。

    Caspase inhibitors and uses thereof
    9.
    发明申请
    Caspase inhibitors and uses thereof 有权
    胱天蛋白酶抑制剂及其用途

    公开(公告)号:US20070010457A1

    公开(公告)日:2007-01-11

    申请号:US11522375

    申请日:2006-09-14

    摘要: The present invention relates to novel classes of compounds of formula I which are caspase and TNF-alpha inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting caspase and TNF-alpha activity and consequently, can be advantageously used as agents against caspase-, interleukin-1-(“IL-1”), apoptosis-, interferon-y inducing factor-(IGIF), interferon-γ-(“IFN-γ”), or TNF-alpha mediated diseases, including inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, and degenerative diseases. This invention also relates to processes for preparing the compounds of this invention. This invention also relates to methods for inhibiting caspase and TNF-alpha activity and decreasing IGIF production and IFN-γ production and methods for treating caspase-, interleukin-1, apoptosis-, and interferon-γ-, and TNF-alpha mediated diseases using the compounds and compositions of this invention.

    摘要翻译: 本发明涉及新型的式I化合物,其为半胱天冬酶和TNF-α抑制剂。 本发明还涉及包含这些化合物的药物组合物。 本发明的化合物和药物组合物特别适用于抑制半胱天冬酶和TNF-α活性,因此可有利地用作抗半胱天冬酶,白细胞介素-1(“IL-1”),细胞凋亡 - 干扰素 - γ诱导因子(IGIF),干扰素-γ-(“IFN-γ”)或TNF-α介导的疾病,包括炎性疾病,自身免疫性疾病,破坏性骨病,增殖性疾病,感染性疾病和退行性疾病。 本发明还涉及制备本发明化合物的方法。 本发明还涉及用于抑制半胱天冬酶和TNF-α活性并减少IGIF产生和IFN-γ产生的方法以及用于治疗半胱天冬酶,白细胞介素-1,细胞凋亡和干扰素γ和TNF-α介导的疾病的方法,其使用 本发明的化合物和组合物。